As the prevalence of excessive sleepiness rises, research from the past year looks at its consequences and potential solutions. Medscape Family Medicine
The FDA has approved first-time generic formulations for oxycodone hydrochloride and ibuprofen tablets in 5 mg/400 mg strength, extended phenytoin sodium capsules in 30-mg strength, and fomepizole injectable in 1 g/mL strength. Medscape Medical News
Two expert neurologists discuss exciting new findings in multiple sclerosis presented at ECTRIMS. Topics discussed include pathogenesis, new therapies, and proper management of patients with MS. Medscape Neurology & Neurosurgery
Higher plasma levels of vitamin C may be linked with a reduced risk for stroke; despite other negative trials, this study suggests low plasma vitamin C may flag those with increased stroke risk. Medscape Medical News
Researchers have found a variant of a gene that has previously been shown to increase peripheral venous thrombosis may also increase the risk for cerebral venous thrombosis. Medscape Medical News
Northstar Neuroscience announced that its trial of cortical stimulation in addition to rehabilitation therapy in stroke survivors failed to meet its primary end point, with no benefit seen over rehabilitation alone. Medscape Medical News
Does medication choice make a difference in functioning in first-episode psychosis? What antipsychotic may be coming to market? Learn the latest in treating psychosis from ACNP 2007. Medscape Psychiatry & Mental Health
How can you help patients with first-episode psychosis avoid relapse? Can depot antipsychotic medications play a role? Learn about new research presented at ACNP 2007.
